Impact Acceleration Account Secondment Awarded

Dr Tim Cannings successfully applied for an EPSRC IAA secondment with Cambridge Cancer Genomics (CCG) to spend time with the company applying statistical research and data science methods to high-dimensional patient genomic data sets. The work is intended to lead towards better outcomes for cancer patients by more accurate predictions of outcomes of different treatment options.